Jump to content

Steven

No Time to Die OS

Recommended Posts





$536M OS till yday including $1.6M OD in AUS.

 

AUS will probably add another ~$24M. Among current markets, UK can add another $7M, Germany another $10M, and all the others can eventually take the total to $625M Approx.

 

DOM probably will final at $160M for $785M final. Really solid result in BOND maxis markets.

 

$425M in Europe + $55M in AUS/NZ & Japan.

  • Like 2
  • Astonished 1
Link to comment
Share on other sites





55 minutes ago, John Marston said:

Solid total. Likely would have made 900-billion in normal times 

I think it would do around what it did now. Reason being non-reliance on market which are currently impacted by CoVID. Also tickets are abnormally increased at many places to set off CoVID in Europe. 

 

Like in Germany, the ATP is EUR11 compared to EUR9.5 of Spectre. In UK its around GBP10+ compared to 8ish of Spectre. Similarily in Nordics.

 

Also lucky that ER got better due to CoVID by 10% or so in most European currency as compared to what they were in 2019.

Edited by charlie Jatinder
  • Like 1
  • Thanks 1
Link to comment
Share on other sites

https://twitter.com/meJat32/status/1459165245784543233?s=20

37 minutes ago, charlie Jatinder said:

I think it would do around what it did now. Reason being non-reliance on market which are currently impacted by CoVID. Also tickets are abnormally increased at many places to set off CoVID in Europe. 

 

Like in Germany, the ATP is EUR11 compared to EUR9.5 of Spectre. In UK its around GBP10+ compared to 8ish of Spectre. Similarily in Nordics.

 

Also lucky that ER got better due to CoVID by 10% or so in most European currency as compared to what they were in 2019.

But it seems the X factor here is the US and China. Would better conditions have created better results in these two markets?

 

NTTD's gross in the US seems to have been hurt by theater hesitancy on the part of older demographics. In China, the under performance seems multi-layered: 1. Universal's marketing tour was scrapped 2. Recent theater closures due to new COVID outbreaks 3. China's hostility toward foreign films.

 

Add to this recurring COVID issues in Russia and Latin America that suppressed the box office in those regions.

Link to comment
Share on other sites



9 minutes ago, Burgess said:

 

NTTD's gross in the US seems to have been hurt by theater hesitancy on the part of older demographics

This was addressed in weekend thread. The problem was lack of young audience for NTTD, not old ones. Bond franchise failed in getting the young demos to the fold.

10 minutes ago, Burgess said:

Add to this recurring COVID issues in Russia and Latin America that suppressed the box office in those regions.

Yeah CoVID did hurt it in LATAM and Asia, but will hardly an issue for Bond, may be $20-30M more.

Link to comment
Share on other sites

1 hour ago, charlie Jatinder said:

I think it would do around what it did now. Reason being non-reliance on market which are currently impacted by CoVID. Also tickets are abnormally increased at many places to set off CoVID in Europe. 

 

Like in Germany, the ATP is EUR11 compared to EUR9.5 of Spectre. In UK its around GBP10+ compared to 8ish of Spectre. Similarily in Nordics.

 

Also lucky that ER got better due to CoVID by 10% or so in most European currency as compared to what they were in 2019.


Very much agree here

Link to comment
Share on other sites



6 hours ago, charlie Jatinder said:

This was addressed in weekend thread. The problem was lack of young audience for NTTD, not old ones. Bond franchise failed in getting the young demos to the fold.

Yeah CoVID did hurt it in LATAM and Asia, but will hardly an issue for Bond, may be $20-30M more.

Fair but $20-30M could be the difference between $750M+ and $800M. It's still money left on the table.

Link to comment
Share on other sites





1 hour ago, Burgess said:

Fair but $20-30M could be the difference between $750M+ and $800M. It's still money left on the table.

Yes but that's with current advantage. Keep the release date in 2019, UK lose $13M to exchange rates, Europe lose $17M.

 

Then there's ticket increase factor. I am waiting for final #s to compile admits, NTTD will be -15% probably in admits from Spectre in Europe.

 

That said $800M may be without CoVID but not $900M+.

Edited by charlie Jatinder
  • Like 1
Link to comment
Share on other sites



Time has changed,Bond will never get back to the Goldfinger and Thunderball level.

It just like Jurassic World will never get back to the Jurassic Park level,Fantsic Beast will never get back to Philoshper stone's level,The Hobbit never get back to TLOR level.

Edited by Bruce
Link to comment
Share on other sites





Of course it would have grossed more. How much is a question, but even in Europe it has clearly been affacted in many places. Sure, there might be some countries where it would have maybe done less as well. The fact that demographics are old doesn't really mean anything, Bond is a franchise that's been around for almost 60 years it's obviously going to have older demographics than most blockbusters. Besides, a uniform increase in audience amongst the demographics would'nt have changed them, and I think it's quite clear that a lot of people still are hesitant to go to cinemas.

 

Besides, No Time To Die is the final film in the Craig-verse and it's a much better film than Spectre so there's no reason why it couldn't have matched Spectre's total in normal circumstances.

Edited by Dale Cooper
Link to comment
Share on other sites







Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.



  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use and Guidelines. Feel free to read our Privacy Policy as well.